Pathkey.ai Limited · ASX:PKY
Pathkey.ai — Investor Presentation (May 2021)
16 slides from Pathkey.ai's investor presentation, May 24, 2021
Slide 1: Introducing: Investor Update
Introducing: Investor Update May 2021 Presented by Michelle Gallaher CEO, Opyl Ltd (ASX:OPL) www.opin.ai
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by Opyl Limited (“Opyl”). Each recipient of this presentation is deemed to have agreed to accept the qualifications, limitations and disclaimers set out below. None of Opyl, its subsidiaries or respective directors, officers, employees, advisers or repr
Slide 3: An Opyl platform
An Opyl platform Matching patients to clinical trials and research studies, anywhere in the world www.opin.ai
Slide 4: Clinical trials and research studies fail to recruit patients on time or on budget
+ 80 % of clinical trials and research studies fail to recruit patients on time or on budget 1 1 11% of study sites fail to enrol a single patient 1 2-5% of cancer patients participate in a clinical trial or study
Slide 5: Cost of each day of trial delay
Each day a pharmaceutical or device trial is delayed, 2 it can cost between USD$600,000 and USD$8 million in lost sales revenue
Slide 6: Clinical trial budget is spent on recruitment
11-40% clinical trial budget is spent on recruitment 2 Av 29k new trials each year 3 4 Av budget of USD$19m per trial 5 Global trials market - USD$44.3bn in 2020 6 US trial support industry growing at 9% p.a 7 Asia-Pac fastest growing support sector Recruitment solution market is competitive
Slide 7: What do patients want?
What do patients want? Patients and carers want to be better and have more good days than bad ones, they want access to the best care and best treatments, they want to feel confident in their choice of care, to prevent others from suffering the way they have and they want to know that they are doing
Slide 8: What do doctors want?
What do doctors want? Doctors want to be able to give their patients the best possible care, accurate, timely, and relevant information they want to access one trusted source that can offer a global and local view of clinical trials, they may want to play a part in clinical research, as well as keep
Slide 9: What do researchers want?
What do researchers want? Researchers want to see their discoveries make a difference to patients, that their discoveries are tested rigorously, safely, and fairly in clinical trials and studies they want the study or trial to begin as quickly as possible and that means attracting eligible motivated
Slide 10: www.opin.ai
www.opin.ai
Slide 11: The winner is: patients
The winner is: patients When patients get what they want, everyone wins 445 condition/disease areas - elastic search Real-time interactive global map Push notification when trial and study opportunities open up Ability to indicate distance prepared to travel Opportunity to participate in ongoing dat
Slide 12: The other winner is: Customers
The other winner is: Customers Improving patient recruitment - saving time & money No onus to upload data or register a trial - automatic Free to access the platform - pay for what you use Ability to pay for a trial to be featured and amplified via social media and search Access to patient database
Slide 13: Opin: How we are different to competitors
Opin: How we are different to competitors Highly competitive market - two win is to market and match well Global view - every trial automatically uploaded Social media firepower - inhouse team of clinical content creators and marketers Search firepower - AI enabled search optimisation and social lis
Slide 14: Opin: access to every clinical trial or study, anywhere in the world
Opin: access to every clinical trial or study, anywhere in the world A patient-led platform amplified via social media and search tools Global database of every registered trial and study - one-stop shop AI identifies eligible patients that have indicated an interest, and then matches patients to tr
Slide 15: Milestones for Opin - Year One
Milestones for Opin - Year One Number of patient profiles registered to the platform over first year - 80k+ Search optimisation statistics - ranking against competitors in disease/condition search Number of customers paying to unlock data - no revenue expectations at this stage, due to early-stage r
Slide 16: www.opin.ai
access to any clinical trial or study anywhere in the world www.opin.ai References 1. Desai, M. Recruitment and retention of participants in clinical studies: Critical Issues and Challenges. Perspectives in Clinical Research. 2020 Apr-Jun; 11(2): 51–53 2. Fassbender, M. Clinical trial cost is a frac